Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020-January, 2022: an observational cohort study
- PMID: 35961858
- PMCID: PMC9363036
- DOI: 10.1016/S2589-7500(22)00125-X
Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020-January, 2022: an observational cohort study
Abstract
Background: Anecdotal reports of menstrual irregularities after receiving COVID-19 vaccines have been observed in post-authorisation and post-licensure monitoring. We aimed to identify and classify reports of menstrual irregularities and vaginal bleeding after COVID-19 vaccination submitted to a voluntary active surveillance system.
Methods: This observational cohort study included recipients of a COVID-19 vaccine who were aged 18 years and older and reported their health experiences to v-safe, a voluntary smartphone-based active surveillance system for monitoring COVID-19 vaccine safety in the USA, from Dec 14, 2020, to Jan 9, 2022. Responses to survey questions on reactions after vaccination were extracted, and a pre-trained natural language inference model was used to identify and classify free-text comments related to menstruation and vaginal bleeding in response to an open-ended prompt about any symptoms at intervals after vaccination. Related responses were further categorised into themes of timing, severity, perimenopausal and postmenopausal bleeding, resumption of menses, and other responses. We examined associations between symptom theme and respondent characteristics, including vaccine type and dose number received, solicited local and systemic reactions reported, and health care sought.
Findings: 63 815 respondents reported on menstrual irregularities or vaginal bleeding, which included 62 679 female respondents (1·0% of 5 975 363 female respondents aged ≥18 years). Common themes identified included timing of menstruation (70 981 [83·6%] responses) and severity of menstrual symptoms (56 890 [67·0%] responses). Other themes included menopausal bleeding (3439 [4·0%] responses) and resumption of menses (2378 [2·8%] responses). Respondents submitting reports related to menopausal bleeding were more likely to seek health care than were those submitting reports related to other menstruation and vaginal bleeding themes.
Interpretation: Reports of heterogeneous symptoms related to menstruation or vaginal bleeding after COVID-19 vaccination are being submitted to v-safe, although this study is unable to characterise the relationship of these symptoms to COVID-19 vaccination. Methods that leverage pretrained models to interpret and classify unsolicited signs and symptoms in free-text reports offer promise in the initial evaluation of unexpected adverse events potentially associated with use of newly authorised or licensed vaccines.
Funding: Centers for Disease Control and Prevention.
Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Figures
Similar articles
-
COVID-19 and abnormal uterine bleeding: potential associations and mechanisms.Clin Sci (Lond). 2024 Feb 21;138(4):153-171. doi: 10.1042/CS20220280. Clin Sci (Lond). 2024. PMID: 38372528 Free PMC article. Review.
-
Abnormal uterine bleeding diagnoses and care following COVID-19 vaccination.Am J Obstet Gynecol. 2024 May;230(5):540.e1-540.e13. doi: 10.1016/j.ajog.2024.01.006. Epub 2024 Jan 12. Am J Obstet Gynecol. 2024. PMID: 38219855
-
Dysmenorrhea, intermenstrual bleeding, menstrual flow volume changes, and irregularities following COVID-19 vaccination and the association with vaccine skepticism: A retrospective observational study.Womens Health (Lond). 2023 Jan-Dec;19:17455057231210094. doi: 10.1177/17455057231210094. Womens Health (Lond). 2023. PMID: 37966030 Free PMC article.
-
The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC's COVID-19 pandemic response.Vaccine. 2023 Feb 10;41(7):1310-1318. doi: 10.1016/j.vaccine.2022.12.031. Epub 2023 Jan 23. Vaccine. 2023. PMID: 36697313 Free PMC article. Review.
-
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe.Lancet Infect Dis. 2022 Jun;22(6):802-812. doi: 10.1016/S1473-3099(22)00054-8. Epub 2022 Mar 7. Lancet Infect Dis. 2022. PMID: 35271805 Free PMC article.
Cited by
-
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data.Hum Vaccin Immunother. 2024 Dec 31;20(1):2315659. doi: 10.1080/21645515.2024.2315659. Epub 2024 Feb 26. Hum Vaccin Immunother. 2024. PMID: 38407186 Free PMC article. Review.
-
Impact of COVID-19 Vaccinations on Menstrual Bleeding.Cureus. 2023 Oct 20;15(10):e47360. doi: 10.7759/cureus.47360. eCollection 2023 Oct. Cureus. 2023. PMID: 38021843 Free PMC article.
-
Effects of COVID-19 vaccination on human fertility: a post-pandemic literature review.Ann Med. 2023 Dec;55(2):2261964. doi: 10.1080/07853890.2023.2261964. Epub 2023 Sep 27. Ann Med. 2023. PMID: 37756386 Free PMC article. Review.
-
Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women.Sci Adv. 2023 Sep 22;9(38):eadg1391. doi: 10.1126/sciadv.adg1391. Epub 2023 Sep 22. Sci Adv. 2023. PMID: 37738335 Free PMC article.
-
Female reproduction and abnormal uterine bleeding after COVID-19 vaccination.Clin Exp Reprod Med. 2023 Jun;50(2):69-77. doi: 10.5653/cerm.2023.05925. Epub 2023 May 16. Clin Exp Reprod Med. 2023. PMID: 37258099 Free PMC article.
References
-
- Centers for Disease Control and Prevention COVID-19 vaccinations in the United States. 2022. https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-...
-
- Chapin-Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA-based COVID-19 vaccines. JAMA. 2021;325:2201–2202. - PubMed
-
- MacNeil JR, Su JR, Broder KR, et al. Updated recommendations from the advisory committee on immunization practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients—United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021;70:651–656. - PMC - PubMed
-
- Von Woon E, Male V. Effect of COVID-19 vaccination on menstrual periods in a prospectively recruited cohort. medRxiv. 2022 doi: 10.1101/2022.03.30.22273165. published online March 30. (preprint). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials